Categories Earnings, Industrials
Earnings: Safe Bulkers slips to Q2 loss on lower revenues; stock falls
Safe Bulkers (NYSE: SB), a provider of marine dry-bulk transportation services, reported a net loss for the second quarter, contrary to the market’s expectations for profit. The bottom-line was hurt by a 3% decline in revenues. The dismal results triggered a selloff and the company’s stock lost sharply Tuesday evening.
Surprise Loss
For the second quarter, Safe Bulkers reported an adjusted loss of $0.01 per share, compared to earnings of $0.02 per share in the same period of last year. Analysts had forecast earnings for the latest quarter. Reported profit was $1.8 million, compared to $4.1 million last year. On a per-share basis, it was an unadjusted loss of $0.01 per share, compared to earnings of $0.01 per share in the year-ago quarter.
At $45.5 million, revenues were lower by 3% from the second quarter of 2018 but slightly above Wall Street’s prediction. The top-line was hurt by a decline in charter rates due to the weakness in the charter market.
Vessel Operation
On average, the company operated 41 vessels during the June-quarter, compared to 39.19 vessels last year. The time charter equivalent rate, which represents charter revenues net of commissions and voyage expenses divided by the number of days, dropped to $11,970 in the second quarter from $13,225 in the same period of 2018.
“In the first half of 2019 the charter market was weak with the BDI averaging 895. Since then the BDI has risen to an average of 1,904 for the 3rd quarter to date and as a consequence we are now entering into charters at much higher rates. We are on track with our environmental investments and about 25% of our planned scrubber installations were commissioned,” said Loukas Barmparis, president of Safe Bulkers.
Stock Plunges
Safe Bulkers’ shares have been trending below their long-term average for quite some time, and often traded below the $2-mark. The stock has lost 16% since the beginning of the year. It dropped about 7% during Tuesday’s extended trading, after closing the regular session higher.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on